Stenocare A/S (CPH:STENO)

Stenocare Statistics

Total Valuation

Stenocare has a market cap or net worth of DKK 49.03 million. The enterprise value is 49.90 million.

Market Cap	49.03M
Enterprise Value	49.90M

Important Dates

The next confirmed earnings date is Thursday, August 20, 2026.

Earnings Date	Aug 20, 2026
Ex-Dividend Date	n/a

Share Statistics

Stenocare has 43.20 million shares outstanding. The number of shares has increased by 69.52% in one year.

Current Share Class	43.20M
Shares Outstanding	43.20M
Shares Change (YoY)	+69.52%
Shares Change (QoQ)	+3.99%
Owned by Insiders (%)	n/a
Owned by Institutions (%)	n/a
Float	33.00M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	5.30
PB Ratio	5.44
P/TBV Ratio	26.90
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Enterprise Valuation

EV / Earnings	-58.34
EV / Sales	5.40
EV / EBITDA	268.86
EV / EBIT	n/a
EV / FCF	n/a

Financial Position

The company has a current ratio of 1.63, with a Debt / Equity ratio of 0.17.

Current Ratio	1.63
Quick Ratio	0.79
Debt / Equity	0.17
Debt / EBITDA	10.07
Debt / FCF	n/a
Interest Coverage	-0.50

Financial Efficiency

Return on equity (ROE) is -14.94% and return on invested capital (ROIC) is -2.93%.

Return on Equity (ROE)	-14.94%
Return on Assets (ROA)	-1.77%
Return on Invested Capital (ROIC)	-2.93%
Return on Capital Employed (ROCE)	-3.33%
Weighted Average Cost of Capital (WACC)	7.73%
Revenue Per Employee	2.31M
Profits Per Employee	-213,804
Employee Count	4
Asset Turnover	0.87
Inventory Turnover	6.49

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has increased by +174.70% in the last 52 weeks. The beta is 0.50, so Stenocare's price volatility has been lower than the market average.

Beta (5Y)	0.50
52-Week Price Change	+174.70%
50-Day Moving Average	1.08
200-Day Moving Average	1.33
Relative Strength Index (RSI)	49.83
Average Volume (20 Days)	167,782

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, Stenocare had revenue of DKK 9.24 million and -855,216 in losses. Loss per share was -0.02.

Revenue	9.24M
Gross Profit	2.99M
Operating Income	-300,577
Pretax Income	-855,216
Net Income	-855,216
EBITDA	151,156
EBIT	-300,577
Loss Per Share	-0.02

Balance Sheet

The company has 654,071 in cash and 1.52 million in debt, with a net cash position of -868,518 or -0.02 per share.

Cash & Cash Equivalents	654,071
Total Debt	1.52M
Net Cash	-868,518
Net Cash Per Share	-0.02
Equity (Book Value)	9.01M
Book Value Per Share	0.21
Working Capital	1.79M

Cash Flow

Operating Cash Flow	-3.84M
Capital Expenditures	n/a
Depreciation & Amortization	451,733
Net Borrowing	-1.51M
Free Cash Flow	n/a
FCF Per Share	n/a

Margins

Gross margin is 32.31%, with operating and profit margins of -3.25% and -9.25%.

Gross Margin	32.31%
Operating Margin	-3.25%
Pretax Margin	-9.25%
Profit Margin	-9.25%
EBITDA Margin	1.64%
EBIT Margin	-3.25%
FCF Margin	n/a

Dividends & Yields

Stenocare does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-69.52%
Shareholder Yield	-69.52%
Earnings Yield	-1.74%
FCF Yield	n/a

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value	n/a
Lynch Upside	n/a
Graham Number	n/a
Graham Upside	n/a

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

Stenocare has an Altman Z-Score of 10.57 and a Piotroski F-Score of 2.

Altman Z-Score	10.57
Piotroski F-Score	2